BNP Paribas High Yield Conference

15 January 2015

Safe Harbor Statement

This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking statements involve risk and uncertainty. Forward-looking statements represent the company's judgment regarding future events, and are based on currently available information. Consequently the company cannot guarantee their accuracy and their completeness, and actual results may differ materially from those the company anticipated due to a number of uncertainties, many of which the company is not aware of. For additional information concerning these and other important factors that may cause the company's actual results to differ materially from expectations and underlying assumptions, please refer to the reports filed by the company with the ‘Autorité des Marchés Financiers’.

Cegedim Group Activities

Financial Performance

Agenda

Cegedim Group Activities

5 This document should not be distributed without Cegedim authorization – Copyright 2014

Cegedim Today

6 This document should not be distributed without Cegedim authorization – Copyright 2014

Two Different Strategies

7 This document should not be distributed without Cegedim authorization – Copyright 2014

Two Different Strategies

8 This document should not be distributed without Cegedim authorization – Copyright 2014

Definitive Purchase Agreement Executed

9 This document should not be distributed without Cegedim authorization – Copyright 2014

Next Steps on IMS Health Transaction

10 This document should not be distributed without Cegedim authorization – Copyright 2014

IMS Health Transaction: FAQ

11 This document should not be distributed without Cegedim authorization – Copyright 2014

Two Different Strategies

12 This document should not be distributed without Cegedim authorization – Copyright 2014

Based on FY 2013 proforma figures

New Cegedim: Key Proforma Figures

13 This document should not be distributed without Cegedim authorization – Copyright 2014

Based on FY 2013 proforma figures

Healthcare Professionals Division

14 This document should not be distributed without Cegedim authorization – Copyright 2014

Based on 2013 figures

Cegedim Healthcare Software

15 This document should not be distributed without Cegedim authorization – Copyright 2014

Based on FY 2013 proforma figures

Insurance & Services Division

16 This document should not be distributed without Cegedim authorization – Copyright 2014

Based on 2013 figures

Cegedim Assurances

17 This document should not be distributed without Cegedim authorization – Copyright 2014

Cegedim SRH

18 This document should not be distributed without Cegedim authorization – Copyright 2014

Cegedim e-business

19 This document should not be distributed without Cegedim authorization – Copyright 2014

Based on FY 2013 proforma figures

GERS Activities & Reconciliation Division

20 This document should not be distributed without Cegedim authorization – Copyright 2014

Seismic Changes in Healthcare

21 This document should not be distributed without Cegedim authorization – Copyright 2014

Cegedim Will Remain on Attractive Markets

Cegedim Strengths

22 This document should not be distributed without Cegedim authorization – Copyright 2014

Financial Performance

24 This document should not be distributed without Cegedim authorization – Copyright 2014

Seasonality and Currency Impact on Business

25 This document should not be distributed without Cegedim authorization – Copyright 2014

9M-2014 Balance Sheet

26 This document should not be distributed without Cegedim authorization – Copyright 2014

New Cegedim Proforma Capex

27 This document should not be distributed without Cegedim authorization – Copyright 2014

Debt Situation

28 This document should not be distributed without Cegedim authorization – Copyright 2014

9M-2014 Figures

29 This document should not be distributed without Cegedim authorization – Copyright 2014

FY 2014 Outlook

30 This document should not be distributed without Cegedim authorization – Copyright 2014

Next Events

31 This document should not be distributed without Cegedim authorization – Copyright 2014

2015 Financial Agenda

Our IR App is now available

32 This document should not be distributed without Cegedim authorization – Copyright 2014

First Nine Months 2014 Financial Situation

34 This document should not be distributed without Cegedim authorization – Copyright 2014

First 9M 2014 Takeaways

35 This document should not be distributed without Cegedim authorization – Copyright 2014

CRM & Strategic Data Review

Significantly negative currency impact Positive impact on EBITDA from:

• Compliance activities

• OneKey database-related products

Improvement of Profitability of market research activity improved during the first 9 months

36 This document should not be distributed without Cegedim authorization – Copyright 2014

Healthcare Professionals Review

• Less demanding comparison level for UK doctors software

• Margin improvement in software for pharmacists activity in France in Q3

• Robust growth in France in products for paramedical professions (nurses, etc.)

• Positive development of RNP activity

37 This document should not be distributed without Cegedim authorization – Copyright 2014

Insurance & Services Review

• Transition from a perpetual license model to a SaaS model at Cegedim Global Payments

• Significant investment in Kadrige

• Profitability increase thanks to:

• Activity for Health Insurance companies

• Cegedim SRH

38 This document should not be distributed without Cegedim authorization – Copyright 2014

GERS Activities & Reconciliation Review

Favorable trend in EBITDA reflects the virtual stability of corporate costs and the gradual return to breakeven at GERS activities

39 This document should not be distributed without Cegedim authorization – Copyright 2014

From Revenue to EBITDA

40 This document should not be distributed without Cegedim authorization – Copyright 2014

From EBITDA to EBIT

41 This document should not be distributed without Cegedim authorization – Copyright 2014

From EBIT to Net Profit

42 This document should not be distributed without Cegedim authorization – Copyright 2014

Net Debt Trend

Thank you. We welcome your questions and comments

Jan Eryk UMIASTOWSKI Chief Investment Officer

Head of Investor Relations

Janeryk.umiastowski@cegedim.com www.cegedim.com/finance

TEL: +33 (0) 1 49 09 33 36

Diapositive numéro 1Safe Harbor StatementAgendaCegedim Group ActivitiesDiapositive numéro 5Diapositive numéro 6Diapositive numéro 7Diapositive numéro 8Diapositive numéro 9Diapositive numéro 10Diapositive numéro 11Diapositive numéro 12Diapositive numéro 13Diapositive numéro 14Diapositive numéro 15Diapositive numéro 16Diapositive numéro 17Diapositive numéro 18Diapositive numéro 19Diapositive numéro 20Diapositive numéro 21Cegedim StrengthsFinancial PerformanceDiapositive numéro 24Diapositive numéro 25Diapositive numéro 26Diapositive numéro 27Diapositive numéro 28Diapositive numéro 29Diapositive numéro 30Diapositive numéro 31Our IR App is now available First Nine Months 2014�Financial SituationDiapositive numéro 34Diapositive numéro 35Diapositive numéro 36Diapositive numéro 37Diapositive numéro 38Diapositive numéro 39Diapositive numéro 40Diapositive numéro 41Diapositive numéro 42Diapositive numéro 43